COMPLEX ASSESSMENT OF RISK FACTORS FOR PRECISE CHOICE OF REVASCULARIZATION STRATEGY IN ST ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY DISEASE
https://doi.org/10.15829/1560-4071-2016-2-43-51
Abstract
Aim. Invention of the model of differentiated strategy selection of revascularization in acute myocardial infarction with ST elevation (STEMI) and multivessel disease (MVD).
Material and methods. Totally, 327 patients with STEMI and MVD included, undergoing primary transcutaneous coronary intervention (PCI). Patients were selected into 2 groups: (1) Multivessel stenting (MVS) during primary PCI (n=91); (2) Staged revascularization (SR) (n=236). The endpoints for 12 months follow-up were significant adverse cardiovascular events. Inside every group the relative level of an adverse outcome was calculated and prognostic coefficient invented that makes possible to estimate significance of every including clinical and demographic and angiographic parameter in the development of adverse outcome.
Results. The most negative prognostic significance for adverse outcome in patients undergoing MVS for primary PCI had the following factors: (1) post infarction cardiosclerosis, (2) severe coronary atherosclerosis (SYNTAX ≥23 points), (3) older age (≥65 y.o.), (4) female gender. Concerning SR: (1) anamnesis of stroke, (2) post infarction cardiosclerosis, (3) multifocal atherosclerosis, (4) three-vessel coronary disease (5) non-drug eluting stents.
Conclusion. Taking into account the complex of clinical and demographic, anatomic and angiographic factors facilitates the improvement of treatment results in STEMI by defining of optimal revascularization strategy.
About the Authors
R. S. TarasovRussian Federation
Kemerovo
V. I. Ganyukov
Russian Federation
Kemerovo
E. S. Kagan
Russian Federation
Kemerovo
O. L. Barbarash
Russian Federation
Kemerovo
L. S. Barbarash
Russian Federation
Kemerovo
References
1. Dambrink JHE, Debrauwere JP, van ’t Hof AWJ, et al. Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines? Eurointervention. 2010; 5: 968-75.
2. Cardarelli F, Bellasi A, Fang-Shu Ou, et al. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry). Am. J. Cardiol. 2009; 103: 766-71.
3. Tarasov RS, Ganyukov VI, Barbarash OL, et al. The Specification of Revascularization Strategy in Patients with ST-elevation Myocardial Infarction and Multi-vessel Disease. Pathology of Circulation and Cardiac surgery 2011; 2:33-37. Russian (Тарасов Р.С., Ганюков В.И., Барбараш О.Л., и др. Выбор стратегии реваскуляризации у больных инфарктом миокарда с элевацией сегмента ST при многососудистом поражении. Патология кровообращения и кардиохирургия 2011; 2: 33-7).
4. Kushner FG, Hand M, Smith SC, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. J. Am. Coll. Cardiol. 2009; 54: 2205-41.
5. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. The new England journal of medicine. 2009; 360(10): 961-72.
6. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the SYNTAX study. EuroIntervention. 2009; 5: 50-6.
7. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005; 1: 219-27.
8. Farooq V, van Klaveren D, Steyerberg EW, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013; 381: 639-50.
9. Yang CH, Hsieh MJ, Chen CC, et al. SYNTAX score: an independent predictor of long-term cardiac mortality in patients with acute ST-elevation myocardial infarction. Coron Artery Dis. 2012; 23(7): 445-49.
10. Khattab AA, Abdel-Wahab M, Rother C, et al. Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single center experience. Clin. Res. Cardiol. 2008; 97: 32-8.
11. Aboyans V, Desormais I, Lacroix P, et al. The general prognosis of patients with peripheral artery disease differs according to the disease localization. J Am. Coll. Cardiol. 2010; 55: 898-903.
12. Politi L, Sgura F, Rossi R, et al. A randomised trial of target-vessel versus multi-vessel revascularization in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart 2010; 96: 662-7.
13. Shishehbor MH, Amini R, Oliveria LP, et al. Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2008; 1: 227-32.
14. Windecker S, Kolh Ph, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2014; doi:10.1093/eurheartj/ehu278:25-27.
15. Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013; 369(12): 1115-23.
Supplementary files
|
1. Неозаглавлен | |
Subject | ||
Type | Исследовательские инструменты | |
View
(120KB)
|
Indexing metadata ▾ |
Review
For citations:
Tarasov R.S., Ganyukov V.I., Kagan E.S., Barbarash O.L., Barbarash L.S. COMPLEX ASSESSMENT OF RISK FACTORS FOR PRECISE CHOICE OF REVASCULARIZATION STRATEGY IN ST ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY DISEASE. Russian Journal of Cardiology. 2016;(2):43-51. (In Russ.) https://doi.org/10.15829/1560-4071-2016-2-43-51